Houlihan Lokey Advises BLUE Software

Houlihan Lokey is pleased to announce that BLUE Software, LLC, a portfolio company of Diversis Capital, LLC, has been acquired by Esko-Graphics, Inc., an operating subsidiary of Danaher Corp. (NYSE:DHR). The transaction closed on July 17, 2018. 

Headquartered in Chicago, Illinois, BLUE Software is the leading provider of label and artwork management (LAM) SaaS applications that simplify the label and packaging process through automated workflows, online proofing tools, and digital asset management solutions. BLUE Software has developed significant domain expertise over a 20-year history serving the largest consumer packaged goods, retail, and pharmaceutical companies.

Founded in 2013, Diversis is an operationally focused private equity firm that executes control investments in middle-market companies primarily within the technology industry. The firm is headquartered in Los Angeles, California.

Esko, a subsidiary of Danaher Corp., is a global provider of software and hardware for packaging design, collaboration, automation, workflow, and production. The Esko product portfolio supports and manages the packaging and print processes for brand owners, retailers, designers, premedia and trade shops, packaging manufacturers, and converters.

Danaher is a global science and technology innovator that designs, manufactures, and markets medical, industrial, and commercial products and services across its five strategic platforms: Life Sciences, Diagnostics, Dental, Water Quality, and Product Identification. Danaher is headquartered in Washington, D.C.

Houlihan Lokey served as the exclusive financial advisor to Blue Software and assisted in structuring and negotiating the transaction on its behalf. This transaction represents Houlihan Lokey's continued position as a leading advisor within the manufacturing technology industry. 

VIEW ALL TRANSACTIONS

You are about to leave
Houlihan Lokey's website

The link below leads to a website that is not
owned by Houlihan Lokey.


Continue to the external website,
or
close the window to remain on HL.com